Q32 Bio Inc. revenue breakdown overview

Q32 Bio Inc. revenue for the last year amounted to -6.70 M USD, the most of which — 1.16 M USD — came from its highest performing source at the moment, Proprietary Gene Editing and Gene Therapy Technology, the year earlier bringing 3.21 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Q32 Bio Inc. 1.16 M USD, and the year before that — 3.21 M USD.